Medical Informatics Corp

Medical Informatics Corp specialises in clinical data interfacing software, specifically tools that integrate and manage electronic health records, patient data, and outputs from medical devices. Their core product, the Sickbay Clinical Platform, focuses on enabling seamless interoperability between clinical systems to support diagnostic, treatment, and administrative workflows. This category falls under software-as-a-medical-device (SaMD) solutions, designed to enhance data exchange and decision-making in healthcare environments.

Medical Informatics Corp is headquartered in the United States, which means its devices are subject to FDA regulatory requirements. Since their primary product, the Sickbay Clinical Platform, is classified as Class II, it undergoes premarket review through 510(k) notifications and must comply with Unique Device Identification (UDI) rules. The FDA’s jurisdiction ensures consistency in safety, performance, and data integrity standards for healthcare software used across the country.

The Sickbay Clinical Platform is authorised and listed in the FDA’s 510(k) premarket notification database and the FDA’s Unique Device Identifier (UDI) registry. These listings confirm the device’s compliance with FDA requirements and provide transparency on its regulatory status. The UDI system, in particular, ensures traceability and standardised identification for tracking and recall purposes.

The Sickbay Clinical Platform is classified as a Class II medical device by the FDA. This classification is based on its intended use—facilitating clinical data integration and interoperability—which presents moderate risks to patients. Class II devices require premarket notification (510(k)) to demonstrate substantial equivalence to a predicate device, ensuring they meet performance and safety standards without needing the stricter controls of Class III. The classification reflects the balance between innovation and regulatory oversight for software-driven healthcare solutions.